Trading · Founded 1996 · www.drhlsl.com · BSE 539267 · · ISIN INE579N01018
No Notes Added Yet
Business
Samsrita Labs Ltd. operates in the trading sector in India. As a trading company, its core business model involves sourcing and selling goods, commodities, or potentially specialized products. The company aims to generate revenue by capitalizing on price differences (buying at a lower price and selling at a higher price), through commissions on transactions, or by managing inventory effectively to benefit from market movements. While the "Labs" in its name might suggest a focus on laboratory-related items, chemicals, or pharmaceuticals, without further detail, it generally engages in the intermediary function of facilitating trade.
Revenue Mix
Specific information regarding Samsrita Labs Ltd.'s key business segments or detailed revenue mix is not available from the provided data. Typically, a trading company might segment its operations by product category (e.g., industrial chemicals, agricultural commodities, consumer goods), geographical markets, or type of client.
Industry
The trading industry in India is generally fragmented and highly competitive, characterized by numerous players ranging from small local traders to large diversified conglomerates. Barriers to entry for basic trading are relatively low, but success often depends on strong sourcing networks, efficient logistics, deep market knowledge, and robust client relationships. Samsrita Labs Ltd. likely competes on factors such as price competitiveness, supply chain efficiency, access to specific markets or products, and timely execution. Its positioning within this industry would depend on its specific niche or scale, which is not ascertainable from the given information.
MOAT
For a general trading company, establishing durable competitive advantages (moats) can be challenging. Most trading businesses operate with relatively thin margins, and advantages are often operational rather than structural. Potential competitive advantages could include proprietary sourcing relationships, exclusive distribution rights, superior market intelligence, highly efficient logistics and working capital management, or significant capital scale for large-volume trades. Based on the limited information, it is not evident that Samsrita Labs Ltd. possesses a strong, durable competitive moat. Its advantages are more likely operational efficiencies or niche expertise.
Growth Drivers
Key factors that could drive growth for Samsrita Labs Ltd. over the next 3-5 years include:
Economic Growth: A robust Indian economy would generally lead to increased demand for various goods and commodities, benefiting trading activities.
Expansion into New Markets/Products: Successfully identifying and entering new geographical markets or diversifying into high-demand product categories.
Supply Chain Optimization: Improving sourcing, logistics, and inventory management to enhance efficiency and margins.
Digital Transformation: Leveraging technology for better market intelligence, faster transactions, and improved customer service.
Favorable Trade Policies: Government policies promoting domestic and international trade.
Risks
Commodity Price Volatility: Fluctuations in the prices of goods being traded can significantly impact profitability.
Currency Fluctuations: For international trade, adverse movements in foreign exchange rates can erode margins.
Intense Competition: High competition can lead to margin pressure and difficulty in sustaining market share.
Supply Chain Disruptions: Geopolitical events, natural disasters, or logistical challenges can disrupt supply and demand.
Credit Risk: Default by counterparties on payment obligations.
Regulatory Changes: Changes in trade policies, tariffs, or taxation can impact business operations and profitability.
Economic Downturns: Reduced consumer and industrial demand during an economic slowdown directly impacts trading volumes.
Management & Ownership
Specific details regarding the promoters, management team's background, or the precise ownership structure of Samsrita Labs Ltd. are not available. In Indian companies, promoter groups often hold significant stakes and are typically involved in the strategic direction and daily operations of the business. The quality of management and their experience in navigating the complexities of the trading sector would be crucial for the company's performance.
Outlook
Samsrita Labs Ltd., as a trading company, operates in a sector characterized by high volume and potentially thin margins, with performance heavily influenced by economic cycles, commodity price trends, and supply chain efficiency.
Bull Case: If the company has established strong sourcing networks, efficient operational processes, and a niche in high-demand products, it could capitalize on India's economic growth and expanding trade opportunities. Strategic diversification and adept risk management could lead to stable profitability.
Bear Case: The company faces significant risks from intense competition, price volatility, and supply chain disruptions. A lack of unique competitive advantages or poor risk management could lead to margin erosion and vulnerability to market downturns.
The company's future performance will largely depend on its specific trading focus, management's ability to navigate market dynamics, and its operational efficiencies in a highly competitive environment.
| #(Fig in Cr.) | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 3 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -3 | -0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -3 | -0 | -0 |
| Provision for Tax | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -3 | -0 | -0 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -3 | -0 | -0 |
| Adjusted Earnings Per Share | -0.2 | -0.2 | -0.1 | -0 | -0 | -0 | -2 | -1.3 | -0.2 | -0.1 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 1 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 2 | 2 | 4 | 4 | 1 | 0 | 1 | 0 | 0 | 9 | 8 |
| Operating Profit | -1 | -1 | -2 | -2 | -1 | 2 | -1 | -0 | -0 | -9 | -8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -1 | -2 | -2 | -1 | 1 | -1 | -0 | -0 | -9 | -8 |
| Provision for Tax | 1 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -1 | -1 | -2 | -2 | -1 | 1 | -1 | -0 | -0 | -9 | -8 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | 1 | 0 |
| Profit After Adjustments | -1 | -1 | -2 | -2 | -1 | 1 | -1 | -0 | -0 | -8 | -8 |
| Adjusted Earnings Per Share | -0.8 | -0.9 | -1.6 | -1.3 | -0.5 | 1 | -0.5 | -0.2 | -0.2 | -3.6 | -3.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -41% | -11% | -16% | 3% |
| ROE Average | -73% | -26% | -14% | -14% |
| ROCE Average | -62% | -22% | -12% | -10% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 8 | 11 | 12 | 12 | 11 | 13 | 13 | 12 | 12 | 12 |
| Minority's Interest | 4 | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 7 | 7 | 10 | 12 | 5 | 4 | 3 | 3 | 3 | 3 |
| Total Liabilities | 19 | 23 | 26 | 28 | 17 | 17 | 16 | 16 | 16 | 14 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 15 | 18 | 20 | 21 | 10 | 10 | 10 | 10 | 10 | 12 |
| Total Current Assets | 3 | 4 | 6 | 7 | 7 | 7 | 5 | 6 | 6 | 3 |
| Total Assets | 19 | 23 | 26 | 28 | 17 | 17 | 16 | 16 | 16 | 14 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | -3 | -3 | -1 | -0 | -0 | 1 | -0 | -0 | -4 |
| Cash Flow from Investing Activities | -1 | -1 | -2 | -1 | -0 | 0 | 0 | 0 | 0 | 3 |
| Cash Flow from Financing Activities | 1 | 5 | 4 | 2 | 1 | 0 | -1 | 0 | 0 | 3 |
| Net Cash Inflow / Outflow | -0 | 0 | -0 | 0 | -0 | 0 | -0 | -0 | -0 | 2 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.81 | -0.88 | -1.62 | -1.31 | -0.52 | 1 | -0.48 | -0.18 | -0.19 | -3.59 |
| CEPS(Rs) | -1.26 | -0.88 | -1.67 | -1.33 | -0.51 | 1.02 | -0.47 | -0.17 | -0.17 | -3.82 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 7.67 | 8.36 | 8.47 | 7.96 | 7.53 | 8.93 | 8.45 | 8.28 | 8.09 | 5.17 |
| Core EBITDA Margin(%) | -45.59 | -182.31 | -121.16 | -152.7 | -6977.89 | -1775.59 | -4555.07 | 0 | 0 | 0 |
| EBIT Margin(%) | -45.62 | -179.69 | -116.59 | -142.79 | -5913.07 | 6690.17 | -3254.58 | 0 | 0 | 0 |
| Pre Tax Margin(%) | -45.66 | -180.17 | -116.89 | -143.36 | -5933.42 | 6673.15 | -3260.39 | 0 | 0 | 0 |
| PAT Margin (%) | -102.1 | -170.09 | -115.56 | -138.4 | -5933.42 | 6673.15 | -3260.39 | 0 | 0 | 0 |
| Cash Profit Margin (%) | -101.01 | -168.15 | -114.65 | -137.26 | -5859.41 | 6697.03 | -3243.13 | 0 | 0 | 0 |
| ROA(%) | -6.9 | -5.06 | -9.63 | -7.4 | -3.47 | 8.89 | -4.32 | -1.61 | -1.67 | -58 |
| ROE(%) | -16.62 | -11.85 | -21.62 | -16.88 | -6.71 | 12.29 | -5.48 | -2.02 | -2.14 | -73.22 |
| ROCE(%) | -4.07 | -6.81 | -12.27 | -10.1 | -4.53 | 10.2 | -4.61 | -1.71 | -1.79 | -62.45 |
| Receivable days | 933.14 | 1819.47 | 460.79 | 559.21 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0.37 | 28.56 | 23.05 | 37.01 | 3662.73 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 12.72 | 300.18 | 239.66 | 442.2 | 0 | 494.66 | 1401.24 | 0 | 0 | 582.01 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 28.38 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 1.8 | 5.51 | 3.66 | 0 | 5.8 | 3.19 | 2.65 | 1.8 | 1.73 | 3.07 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 16.08 | 98.28 | 25.17 | 16.32 | 5162.99 | 2001.26 | 1626.87 | 0 | 0 | 1991.52 |
| EV/Core EBITDA(x) | -36.12 | -55.29 | -21.76 | -11.52 | -88.42 | 29.81 | -50.25 | -98.39 | -90.2 | -4.16 |
| Net Sales Growth(%) | 0 | -51.85 | 226.64 | -28.92 | -99.09 | 73.09 | -3.61 | -100 | 0 | 0 |
| EBIT Growth(%) | 0 | -89.64 | -111.94 | 12.95 | 62.48 | 295.84 | -146.89 | 64.73 | -3.87 | -3265.38 |
| PAT Growth(%) | 0 | 19.78 | -121.92 | 14.88 | 61.16 | 294.67 | -147.1 | 64.59 | -3.83 | -3247.46 |
| EPS Growth(%) | 0 | -9.27 | -83.98 | 19.27 | 60.15 | 292.65 | -147.55 | 62.91 | -8.58 | -1765.31 |
| Debt/Equity(x) | 0.83 | 0.69 | 0.68 | 0.73 | 0.21 | 0.21 | 0.17 | 0.18 | 0.2 | 0.14 |
| Current Ratio(x) | 0.46 | 0.56 | 0.59 | 0.54 | 1.31 | 1.84 | 1.86 | 1.72 | 1.59 | 1 |
| Quick Ratio(x) | 0.46 | 0.54 | 0.57 | 0.52 | 1.28 | 1.84 | 1.86 | 1.72 | 1.59 | 1 |
| Interest Cover(x) | -1242.02 | -373.68 | -388.72 | -251.14 | -290.59 | 393.15 | -560.85 | -170.75 | -182.25 | -7532.35 |
| Total Debt/Mcap(x) | 0.46 | 0.13 | 0.18 | 0 | 0.04 | 0.06 | 0.06 | 0.1 | 0.12 | 0.05 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.87 | 52.87 | 52.87 | 52.87 | 49.27 | 48.25 | 31.41 | 25.44 | 25.44 | 25.44 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 47.13 | 47.13 | 47.13 | 47.13 | 50.73 | 51.75 | 68.59 | 74.56 | 74.56 | 74.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.78 | 0.78 | 0.78 | 0.78 | 0.73 | 0.71 | 0.71 | 0.58 | 0.58 | 0.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.7 | 0.7 | 0.7 | 0.7 | 0.75 | 0.77 | 1.56 | 1.7 | 1.7 | 1.7 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 2.27 | 2.27 | 2.27 | 2.27 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | — | — |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | -41% | -11% | -16% | +3% |
| ROE Average | -73% | -26% | -14% | -14% |
| ROCE Average | -62% | -22% | -12% | -10% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.87 | 52.87 | 52.87 | 52.87 | 49.27 | 48.25 | 31.41 | 25.44 | 25.44 | 25.44 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 47.13 | 47.13 | 47.13 | 47.13 | 50.73 | 51.75 | 68.59 | 74.56 | 74.56 | 74.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.78 | 0.78 | 0.78 | 0.78 | 0.73 | 0.71 | 0.71 | 0.58 | 0.58 | 0.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.7 | 0.7 | 0.7 | 0.7 | 0.75 | 0.77 | 1.56 | 1.7 | 1.7 | 1.7 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 2.27 | 2.27 | 2.27 | 2.27 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.